890044-38-9 (N-[3,5-二(三氟甲基)苯基]-N'-(8α,9S)-奎宁-9-基硫脲,(8S,9S)-9-[3-[3,5-Bis(trifluoromethyl)phenyl]thioureido]cinchonan)

CAS号:
890044-38-9
中文名称:
N-[3,5-二(三氟甲基)苯基]-N'-(8α,9S)-奎宁-9-基硫脲
英文名称:
(8S,9S)-9-[3-[3,5-Bis(trifluoromethyl)phenyl]thioureido]cinchonan
分子式:
C28H26F6N4S
分子量:
564.588265895844

N-[3,5-二(三氟甲基)苯基]-N'-(8α,9S)-奎宁-9-基硫脲(890044-38-9)名称与标识符

名称

中文别名:
普瑞巴林杂质D;N-[3,5-二(三氟甲基)苯基]-N'-(8α,9S)-奎宁-9-基硫脲;
英文别名:
1-(3,5-Bis(trifluoromethyl)phenyl)-3-((1S)-quinolin-4-yl((2R)-5-vinylquinuclidin-2-yl)methyl)thiourea;N-[3,5-Bis(trifluoromethyl)phenyl]-N'-(8α,9S)-cinchonan-9-ylthiourea;(8S,9S)-9-[3-[3,5-Bis(trifluoromethyl)phenyl]thioureido]cinchonan;N-[3,5-Bis(trifluoromethyl)phenyl]-N'-(8;A,9S)-cinchonan-9-ylthiourea;1-[(S)-[(2S,4S,5R)-5-Ethenyl-1-azabicyclo[2.2.2]octane-2-yl](4-quinolinyl)methyl]-3-[3,5-bis(trifluoromethyl)phenyl]thiourea;N-[3,5-Bis(trifluoromethyl)phenyl]-N′-(8α,9S)-cinchonan-9-ylthiourea (ACI);

标识符

MDL:
MFCD28902422
InChIKey:
IIQBCCXHYIEQTC-SEMUBUJISA-N
Inchi:
1S/C28H26F6N4S/c1-2-16-15-38-10-8-17(16)11-24(38)25(22-7-9-35-23-6-4-3-5-21(22)23)37-26(39)36-20-13-18(27(29,30)31)12-19(14-20)28(32,33)34/h2-7,9,12-14,16-17,24-25H,1,8,10-11,15H2,(H2,36,37,39)/t16-,17-,24-,25-/m0/s1
SMILES:
[C@H](C1C=CN=C2C=CC=CC=12)([C@@H]1C[C@@H]2CC[N@@]1C[C@@H]2C=C)NC(=S)NC1C=C(C(F)(F)F)C=C(C(F)(F)F)C=1

N-[3,5-二(三氟甲基)苯基]-N'-(8α,9S)-奎宁-9-基硫脲(890044-38-9)物化性质

计算特性

  • 氢键供体数量 : 2
  • 氢键受体数量 : 9
  • 可旋转化学键数量 : 5
  • 重原子数量 : 39
  • 复杂度 : 859
  • 疏水参数计算参考值(XlogP) : 6.4
  • 拓扑分子极性表面积 : 72.3

N-[3,5-二(三氟甲基)苯基]-N'-(8α,9S)-奎宁-9-基硫脲(890044-38-9)安全信息

N-[3,5-二(三氟甲基)苯基]-N'-(8α,9S)-奎宁-9-基硫脲(890044-38-9)推荐厂家 更多厂家(8)

公司名称手机号/电话联系人QQ微信询单
上海楷森生物科技有限公司 17558870519
175-58870519
赵经理 3003926540
询单
深圳菲斯生物科技有限公司 18925202235周美娇 2850179284
询单
上海瀚思化工有限公司 18939883912
021-34536277
顾经理 3003949364
询单
铼博(上海)生化科技有限公司 13311756052
021-60536361 13311756052 13311756131
张经理 2851717387
询单
深圳振强生物技术有限公司 13670046396
86-755-66853366
颜经理 2851296953
询单
江苏艾康生物医药研发有限公司 18795912720
025-66061636
杨情情 3004779232
询单
上海吉至生化科技有限公司 18117592386
021-57481218
吉至试剂 3007522982
询单
上海源叶生物科技有限公司 15026964105
15026964105
汤思磊 2881489226
询单

N-[3,5-二(三氟甲基)苯基]-N'-(8α,9S)-奎宁-9-基硫脲(890044-38-9)合成路线

合成路线:1 步
反应条件:
参考文献:
Enantioselective organocatalytic formal [3+2]-cycloaddition of isatin-derived ketimines with benzylidenemalononitriles and benzylidineindanones
Duffy, Conor; Roe, William E.; Harkin, Aislinn M.; McNamee, Ryan; Knipe, Peter C., New Journal of Chemistry, 2021, 45(47), 22034-22038
合成路线:1 步
反应条件:
参考文献:
Enantioselective construction of quaternary carbon centre catalyzed by bifunctional organocatalyst
Liu, Tian-Yu; Long, Jun; Li, Bang-Jing; Jiang, Lin; Li, Rui; et al, Organic & Biomolecular Chemistry, 2006, 4(11), 2097-2099
合成路线:1 步
反应条件:
参考文献:
Catalytic Asymmetric Synthesis of α,β-Disubstituted α,γ-Diaminophosphonic Acid Precursors by Michael Addition of α-Substituted Nitrophosphonates to Nitroolefins
Tripathi, Chandra Bhushan; Kayal, Satavisha; Mukherjee, Santanu, Organic Letters, 2012, 14(13), 3296-3299
合成路线:1 步
反应条件:
参考文献:
Stereoselective reaction of 2-carboxythioesters-1,3-dithiane with nitroalkenes: an organocatalytic strategy for the asymmetric addition of a glyoxylate anion equivalent
Massolo, Elisabetta; Benaglia, Maurizio; Genoni, Andrea; Annunziata, Rita; Celentano, Giuseppe; et al, Organic & Biomolecular Chemistry, 2015, 13(20), 5591-5596
合成路线:1 步
反应条件:
参考文献:
Synthesis, antibacterial and anti-MRSA activity, in vivo toxicity and a structure-activity relationship study of a quinoline thiourea
Dolan, Niamh; Gavin, Declan P.; Eshwika, Ahmed; Kavanagh, Kevin; McGinley, John; et al, Bioorganic & Medicinal Chemistry Letters, 2016, 26(2), 630-635
合成路线:1 步
反应条件:
参考文献:
Desymmetrization of gem-diols via water-assisted organocatalytic enantio- and diastereoselective cycloetherification
Murata, Ryuichi; Matsumoto, Akira; Asano, Keisuke; Matsubara, Seijiro, Chemical Communications (Cambridge, 2020, 56(82), 12335-12338
合成路线:1 步
反应条件:
参考文献:
Asymmetric Cycloetherification by Bifunctional Organocatalyst
Asano, Keisuke ; Matsubara, Seijiro, Synthesis, 2018, 50(21), 4243-4253